Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?

[1]  S. Choi,et al.  Long‐term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study , 2017, Journal of hepato-biliary-pancreatic sciences.

[2]  J. Cameron,et al.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma , 2017, Annals of surgery.

[3]  J. Boughey,et al.  Improving resection rates in borderline resectable pancreatic cancer: Pilot study shows favorable results. , 2015, Bulletin of the American College of Surgeons.

[4]  E. Fishman,et al.  Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns , 2015, Oncotarget.

[5]  M. Katz,et al.  Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma. , 2015, Hematology/oncology clinics of North America.

[6]  Gongfu Zhou,et al.  Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort study. , 2015, Annals of surgery.

[7]  Yuhree Kim,et al.  What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? , 2015, Journal of Gastrointestinal Surgery.

[8]  Lisa M. Schwartz,et al.  Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. , 2014, JAMA internal medicine.

[9]  D. Naidich,et al.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[10]  K. Lillemoe,et al.  Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a “True” R0 Resection? , 2013, Annals of surgery.

[11]  E. Nakakura,et al.  Pancreatic Adenocarcinoma, Version 1.2019. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[12]  R. Hruban,et al.  Pancreatic cancer , 2011, The Lancet.

[13]  J. Cameron,et al.  Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival , 2011, Journal of Gastrointestinal Surgery.

[14]  Nicola Sverzellati,et al.  Incidental lung nodules on CT examinations of the abdomen: prevalence and reporting rates in the PACS era. , 2010, European journal of radiology.

[15]  Patrick Maisonneuve,et al.  Epidemiology of pancreatic cancer: an overview , 2009, Nature Reviews Gastroenterology &Hepatology.

[16]  J. Sand,et al.  Chest computed tomography in the staging of pancreatic and periampullary carcinoma , 2004, Scandinavian journal of gastroenterology.

[17]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[18]  B. Erickson,et al.  Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[19]  E. Nakakura,et al.  Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[20]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.